Ceribell Revenue and Competitors
Estimated Revenue & Valuation
- Ceribell's estimated annual revenue is currently $83.8M per year.
- Ceribell's estimated revenue per employee is $313,750
- Ceribell's total funding is $121M.
- Ceribell has 267 Employees.
- Ceribell grew their employee count by 21% last year.
Ceribell Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Ceribell?
Ceribell is a fast growing venture-backed medical device start-up company founded by two faculty members at Stanford University. We have developed a highly innovative electroencephalography (EEG) device, which will make the diagnosis of neurological patients drastically more efficient. Our device has gained FDA clearance recently and high interest from the market. Ceribell is focused on making EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizure. We've created and validated an FDA cleared instant EEG system that does not require an EEG tech for a long setup or waiting for a specialist to interpret the initial results. The Ceribell system can be set up by any user in less than 6 minutes and offers a proprietary brain stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizure can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that need EEG for detection, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.keywords:N/A
Number of Employees
Employee Growth %
Mount Sinai Kravis Children's Hospital has made available the use of the Ceribell Rapid Response device to enable rapid detection and diagnosis of...
Mercy Health Springfield on Tuesday has announced the launch of the new Ceribell Rapid Electroencephalographic (EEG) Brain Monitoring,...
Until now, this technology, known as the Ceribell Rapid Response device, has only been available to adult patients at The Mount Sinai...
MOUNTAIN VIEW, Calif., May 14, 2021 /PRNewswire/ -- Ceribell, Inc., innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced today that Diku Mandavia, MD, has joined the company as Chief Medical Officer. With 27 years of clinical experience and 14 years of commercial ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|